| abstract |
1.- The present invention relates to the use of known imidazotriazinones substituted in position 2 phenyl with short alkyl radicals, not branched in position 9 and with inhibitory properties of cGMP-PDE for the preparation of medicaments for the treatment of insufficiency heart disease, psoriasis, female infertility, cancer, diabetes, eye diseases such as glaucoma, stomach movement disorders, cystic fibrosis, premature contractions, pulmonary hypertension, bladder diseases, prostatic hyperplasia, nitrate-induced tolerance, preeclampsia, alopecia, disease of Parkinson's, pain, tinnitus or renal syndrome. |